Status:
RECRUITING
Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Colorectal cancer (CRC) is the third most common cancer in men and the second in women with an incidence of 43,350 new cases in 2018. This incidence is increasing every year. Early detection is cruci...
Eligibility Criteria
Inclusion
- Patients aged more than18 years
- Cohort A : patients with suspected colorectal cancer following a positive immunological test during screening (presence of blood detected in the stool) or with gross bleeding OR Cohort B : patients who have already performed colonoscopy (on symptoms, or because of family history, or other ...), for whom the diagnosis of adenocarcinoma was identified by pathology prior to surgery, candidates for surgery on their colorectal tumor
- Signed and dated informed consent
- Patient affiliated to or beneficiary of French social security system.
Exclusion
- Vulnerable persons according to the law (minors, adults under protection, persons deprived of liberty ...)
- Not ability to comply with the study protocol, in the Investigator's judgment
- pregnant woman
- Patient in the period of exclusion of another study
Key Trial Info
Start Date :
March 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04767568
Start Date
March 30 2021
End Date
September 1 2028
Last Update
December 27 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Besançon
Besançon, France
2
Hôpital Nord-Franche-Comté
Montbéliard, France
3
Centre Hospitalier Intercommunal de Haute-Saône
Vesoul, France